Unlike semaglutide and tirzepatide, where the FDA has now spent years responding to shortages, compounding, and illicit imports, many of these newer drugs are still investigational
Worth considering before that audit: allostatic load, the cumulative physiological cost of chronic stress across every domain of a patient's life, not just whatever she reports when asked how she's doing
Role of FTO and MC4R polymorphisms in escalating obesity and their indirect association with risk of T2D in Indian population
Instead, ask your doctor about Wegovy , which is approved for weight management and may be covered by BCBS if: Your BMI is 30 or higher , or Your BMI is 27+ with a weight-related condition (e.g., hypertension, high cholesterol, PCOS) 3
Molecules used in chronic weight loss studies were generated by Amgen as previously described and dosing regimens for each molecule were established by previously published pharmacokinetic and pharmacodynamic studies: mGIPR-Ab (25 mg kg 1 every 6 days) 17 , dulaglutide (0.3 mg kg 1 every 3 days) 17 and mGIPR-Ab/P1 or mGIPR-Ab/P3 (1.5 mg kg 1 every 6 days) 16
